4.4 Article

Identification and validation of DPY30 as a prognostic biomarker and tumor immune microenvironment infiltration characterization in esophageal cancer

Related references

Note: Only part of the references are listed.
Review Oncology

Advances in the curative management of oesophageal cancer

Jarlath C. Bolger et al.

Summary: The incidence of oesophageal cancer, particularly adenocarcinoma, has increased in the past four decades, with higher mortality rates. However, overall survival has doubled in the last 20 years, with advancements in early diagnosis and treatments. Endotherapy, surgical approaches, and new combination therapies have shown promise, along with targeted therapies and immunotherapy based on genomics and molecular biology advancements. This review focuses on curative intent treatments and highlights emerging advances.

BRITISH JOURNAL OF CANCER (2022)

Article Medicine, Research & Experimental

Upregulation of DPY30 promotes cell proliferation and predicts a poor prognosis in cholangiocarcinoma

Zai-Fa Hong et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Review Multidisciplinary Sciences

Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma

Xue-Feng Leng et al.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2020)

Article Urology & Nephrology

Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer

Alec Paschalis et al.

EUROPEAN UROLOGY (2019)

Article Biotechnology & Applied Microbiology

DPY30 regulates cervical squamous cell carcinoma by mediating epithelial-mesenchymal transition (EMT)

Feng-xi He et al.

ONCOTARGETS AND THERAPY (2019)

Review Biochemistry & Molecular Biology

Pathogenic and Therapeutic Role of H3K4 Family of Methylases and Demethylases in Cancers

Aman Kumar et al.

INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2019)

Article Oncology

Cancer Statistics, 2018

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Article Gastroenterology & Hepatology

Epidemiology of Esophageal Squamous Cell Carcinoma

Christian C. Abnet et al.

GASTROENTEROLOGY (2018)

Article Medicine, Research & Experimental

Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer

Zhenhua Yang et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Biochemistry & Molecular Biology

DPY30 functions in glucose homeostasis via integrating activated histone epigenetic modifications

Bing Liu

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Medicine, General & Internal

Oesophageal cancer

Elizabeth C. Smyth et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Article Immunology

Dpy30 is critical for maintaining the identity and function of adult hematopoietic stem cells

Zhenhua Yang et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2016)

Review Immunology

Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression

Peter J. Chockley et al.

JOURNAL OF IMMUNOLOGY (2016)

Article Multidisciplinary Sciences

Roles of DPY30 in the Proliferation and Motility of Gastric Cancer Cells

Yong Joo Lee et al.

PLOS ONE (2015)

Article Biochemical Research Methods

GSVA: gene set variation analysis for microarray and RNA-Seq data

Sonja Haenzelmann et al.

BMC BIOINFORMATICS (2013)

Article Biochemistry & Molecular Biology

DPY30 regulates pathways in cellular senescence through ID protein expression

Elisabeth Simboeck et al.

EMBO JOURNAL (2013)

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

Article Biochemistry & Molecular Biology

Crystal Structure of the C-Terminal Domain of Human DPY-30-Like Protein: A Component of the Histone Methyltransferase Complex

Xianping Wang et al.

JOURNAL OF MOLECULAR BIOLOGY (2009)

Article Biochemistry & Molecular Biology

Regulation of MLL1 H3K4 methyltransferase activity by its core components

Yali Dou et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)